Thorne HealthTech Acquires Majority of Drawbridge Health
May 25, 2021
Thorne HealthTech acquired a majority of outstanding shares of Drawbridge Health, the developer of the OneDraw blood collection device and A1C Test System. Drawbridge Health will remain a majority‑owned and controlled subsidiary, with its former CEO Lee McCraken staying on as chairman while new co‑CEOs lead growth and integration efforts.
- Buyers
- Thorne HealthTech
- Targets
- Drawbridge Health
- Industry
- Medical Devices
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Astorg Takes Hamilton Thorne Private and Acquires Cook Medical Reproductive Health
December 2, 2024
Medical Devices
Astorg completed a take-private of Hamilton Thorne and simultaneously acquired Cook Medical’s Reproductive Health business, combining the two to create a global leader in assisted reproductive technology (ART) consumables, instruments and equipment. The combined company will serve fertility clinics and IVF laboratories in over 115 countries, with a new executive team appointed to lead the integrated MedTech platform.
-
L Catterton Completes Acquisition of Thorne HealthTech, Inc.
October 16, 2023
Healthcare Services
L Catterton has completed its acquisition of Thorne HealthTech, Inc. through a tender offer and subsequent second‑step merger, paying $10.20 per share and taking Thorne private. Thorne's common stock will be delisted from the Nasdaq and L Catterton intends to support Thorne's growth and execution of its clinically backed personalized testing and supplement offerings.
-
Thorne HealthTech Acquires PreCon Health
February 3, 2023
Healthcare Services
Thorne HealthTech acquired all outstanding stock of PreCon Health, Inc. on January 31, 2023 for an aggregate purchase price of $5.0 million. The acquisition secures PreCon's brain-health products, related IP and its Medical and Scientific Advisory Board to strengthen Thorne's brain health portfolio and support ongoing clinical research.
-
Scipher Medicine Acquires CrossBridge to Add Real-time Patient Data and Analytics Platform
January 10, 2023
Data & Analytics
Scipher Medicine has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data management and analytics capabilities. The acquisition (closed; terms not disclosed) adds CrossBridge's SaaS value-based care platform to enable real-time mapping of patient molecular, clinical and claims data and to support Scipher's precision immunology offerings such as the PrismRA test.
-
Francisco Partners Makes Strategic Growth Investment in Drawbridge
September 1, 2022
Cybersecurity
Francisco Partners has made a strategic growth investment in Drawbridge, a cybersecurity software provider focused on the alternative investment industry. Existing investor Long Ridge and Drawbridge's leadership team remain significant equity holders; the capital will be used to accelerate product development and expand Drawbridge's market reach. The transaction closed on September 1 with terms undisclosed.
-
Long Ridge Equity Partners Makes Minority Growth Investment in Drawbridge
March 11, 2021
Cybersecurity
Long Ridge Equity Partners has made a minority growth capital investment in Drawbridge, a cybersecurity software provider serving the alternative investment industry. The investment will support Drawbridge's global expansion, accelerate product innovation, and grow its client base; Long Ridge will also place Kevin Bhatt and Jason Melton on Drawbridge's board.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.